901 related articles for article (PubMed ID: 30453864)
1. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
2. Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction.
Roberts JP; Stokoe SA; Sathler MF; Nichols RA; Kim S
J Biol Chem; 2021; 296():100402. PubMed ID: 33571523
[TBL] [Abstract][Full Text] [Related]
3. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.
Dineley KT; Westerman M; Bui D; Bell K; Ashe KH; Sweatt JD
J Neurosci; 2001 Jun; 21(12):4125-33. PubMed ID: 11404397
[TBL] [Abstract][Full Text] [Related]
4. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
[TBL] [Abstract][Full Text] [Related]
5. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
[TBL] [Abstract][Full Text] [Related]
6. N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease.
Bi H; Sze CI
J Neurol Sci; 2002 Aug; 200(1-2):11-8. PubMed ID: 12127670
[TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
[TBL] [Abstract][Full Text] [Related]
8. S 24795 limits beta-amyloid-alpha7 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies.
Wang HY; Bakshi K; Shen C; Frankfurt M; Trocmé-Thibierge C; Morain P
Biol Psychiatry; 2010 Mar; 67(6):522-30. PubMed ID: 19932469
[TBL] [Abstract][Full Text] [Related]
9. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC
Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of long-term depression by soluble amyloid β protein in rat hippocampus is mediated by metabotropic glutamate receptor and involves activation of p38MAPK, STEP and caspase-3.
Chen X; Lin R; Chang L; Xu S; Wei X; Zhang J; Wang C; Anwyl R; Wang Q
Neuroscience; 2013 Dec; 253():435-43. PubMed ID: 24012839
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of beta-amyloid on the nicotinic receptors which stimulate glutamate release in rat hippocampus: the glial contribution.
Salamone A; Mura E; Zappettini S; Grilli M; Olivero G; Preda S; Govoni S; Marchi M
Eur J Pharmacol; 2014 Jan; 723():314-21. PubMed ID: 24275353
[TBL] [Abstract][Full Text] [Related]
12. Probing the putative α7 nAChR/NMDAR complex in human and murine cortex and hippocampus: Different degrees of complex formation in healthy and Alzheimer brain tissue.
Elnagar MR; Walls AB; Helal GK; Hamada FM; Thomsen MS; Jensen AA
PLoS One; 2017; 12(12):e0189513. PubMed ID: 29261717
[TBL] [Abstract][Full Text] [Related]
13. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
[TBL] [Abstract][Full Text] [Related]
14. Dissociating beta-amyloid from alpha 7 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes alpha 7 nicotinic acetylcholine and NMDA receptor function in Alzheimer's disease brain.
Wang HY; Stucky A; Liu J; Shen C; Trocme-Thibierge C; Morain P
J Neurosci; 2009 Sep; 29(35):10961-73. PubMed ID: 19726654
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
16. Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss.
Talantova M; Sanz-Blasco S; Zhang X; Xia P; Akhtar MW; Okamoto S; Dziewczapolski G; Nakamura T; Cao G; Pratt AE; Kang YJ; Tu S; Molokanova E; McKercher SR; Hires SA; Sason H; Stouffer DG; Buczynski MW; Solomon JP; Michael S; Powers ET; Kelly JW; Roberts A; Tong G; Fang-Newmeyer T; Parker J; Holland EA; Zhang D; Nakanishi N; Chen HS; Wolosker H; Wang Y; Parsons LH; Ambasudhan R; Masliah E; Heinemann SF; Piña-Crespo JC; Lipton SA
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):E2518-27. PubMed ID: 23776240
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydroxystilbene glucoside improves the learning and memory of amyloid-β(₁₋₄₂)-injected rats and may be connected to synaptic changes in the hippocampus.
Zhou L; Hou Y; Yang Q; Du X; Li M; Yuan M; Zhou Z
Can J Physiol Pharmacol; 2012 Nov; 90(11):1446-55. PubMed ID: 23181273
[TBL] [Abstract][Full Text] [Related]
18. [Chronic effects of oligomeric Aβ(1-42) on hippocampal synaptic plasticity in vivo].
Tan T; Zhang BL; Tian X
Sheng Li Xue Bao; 2011 Jun; 63(3):225-32. PubMed ID: 21681340
[TBL] [Abstract][Full Text] [Related]
19. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?
Hernandez CM; Dineley KT
Curr Drug Targets; 2012 May; 13(5):613-22. PubMed ID: 22300028
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective amyloid β N-terminal peptides differentially alter human α7- and α7β2-nicotinic acetylcholine (nACh) receptor single-channel properties.
Roberts CF; Cao Y; Im W; Nichols RA; Lukas RJ; George AA
Br J Pharmacol; 2024 May; ():. PubMed ID: 38720171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
